Brainstorm Cell Therapeutics shares owned by Delek Group
Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by Delek Group
from 13F filings
Historical chart of Delek Group investment in Brainstorm Cell Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Brainstorm Cell Therapeutics held by Delek Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Brainstorm Cell Therapeutics by Delek Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2019-06-30 | $139k | 36k | 3.87 |
2019-03-31 | $183k | 42k | 4.32 |